[Clinical observations concerning piracetam treatment of patients after craniocerebral injury].
Piracetam (Nootropil) is a cytoprotective to brain tissue and improving cerebral blood flow medicine. In the Department of Neurotraumatology we investigated results of piracetam treatment in a group of 100 succeeding patients admitted between 1995-96 due to craniocerebral injury. High doses (24-30 g per day) of this medicine have a positive effect on final result of treatment, when treatment is initiated immediately after the injury and described conditions are abided. We also showed usefulness of piracetam treatment in posthospital management.
Gościński
I
I
Kliniki Neurotraumatologii Instytutu Neurologii Collegium Medicum Uniwersytetu Jagiellońskiego w Krakowie.
Moskała
M
M
Cichoński
J
J
Polak
J
J
Krupa
M
M
Sliwonik
S
S
Sondej
T
T
D001930:Brain Injuries / Q000188:drug therapy*; D002560:Cerebrovascular Circulation / Q000187:drug effects; D015600:Glasgow Coma Scale; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010889:Piracetam / Q000627:therapeutic use*; D016896:Treatment Outcome
D018696:Neuroprotective Agents; D010889:Piracetam
Spostrzezenia kliniczne leczenia nootropilem chorych po urazach czaszkowo-mózgowych.